{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T06:34:49Z","timestamp":1778740489203,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Guizhou University of Traditional Chinese Medicine PhD Startup Fund","award":["[2019]124"],"award-info":[{"award-number":["[2019]124"]}]},{"name":"National Science and Technology Project and National 13th Five-Year Science and Technology Project","award":["2016YFD0501310"],"award-info":[{"award-number":["2016YFD0501310"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Improper use of antibiotics results in poor treatment and severe bacterial resistance. In this study, ultrafiltration probes were successfully placed in the ileum of piglets with the aid of anesthetic. After the fluoroquinolone antimicrobial drug danofloxacin (DAN) was intramuscularly administered, blood and ileum ultrafiltrate were collected at different time points and then determined by High Performance Liquid Chromatography (HPLC). Pharmacokinetics (PK) parameters for plasma and ileum ultrafiltrate were calculated by WinNonlin software. The DAN concentration in ileum ultrafiltrate was much higher than that in plasma during the period 1.2\u201348\u00a0h. The DAN concentration in plasma reached its maximum at 1.10\u2009\u00b1\u20090.03\u00a0h, but reached at 6.00\u2009\u00b1\u20090.00\u00a0h in the ileum ultrafiltrate. The mean C<jats:sub>max<\/jats:sub>of the ileum is 13.59 times that of plasma. The elimination half-life (T<jats:sub>1\/2\u03b2<\/jats:sub>) in the ileum ultrafiltrate (6.84\u2009\u00b1\u20091.49\u00a0h) was shorter than those in plasma (7.58\u2009\u00b1\u20093.20\u00a0h). The MIC, MBC and MPC of DAN in MH broth against<jats:italic>Escherichia coli<\/jats:italic>(O<jats:sub>158<\/jats:sub>) were 0.5\u00a0\u00b5g\/mL, 0.5\u00a0\u00b5g\/mL and 4\u00a0\u00b5g\/mL, respectively. Both in vitro and ex vivo kill curves indicated that the killing mechanism of DAN against<jats:italic>E. coli<\/jats:italic>is concentration-dependent. The AUC\/MPC ratio is 21.33\u2009\u00b1\u20092.14. Mean PK\/PD index (AUC<jats:sub>24h<\/jats:sub>\/MIC) for ileum ultrafiltrate that achieved bacteriostatic, bactericidal, and eradication were 99.85, 155.57, and 218.02\u00a0h, respectively. Three different dosages (1.49\u00a0mg\/kg, 2.42\u00a0mg\/kg, and 3.24\u00a0mg\/kg) were calculated respectively based on AUC<jats:sub>24h<\/jats:sub>\/MIC ratio above, which might provide a novel approach to the rational design of dosage schedules.<\/jats:p>","DOI":"10.1038\/s41598-020-80272-7","type":"journal-article","created":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T19:24:12Z","timestamp":1610479452000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Pharmacokinetics and pharmacodynamics integration of danofloxacin against Eschrichia coli in piglet ileum ultrafiltration probe model"],"prefix":"10.1038","volume":"11","author":[{"given":"Yuqi","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianshi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jargalsaikhan","family":"Ulziikhutag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxiao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiarui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruimeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ishfaq","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,12]]},"reference":[{"key":"80272_CR1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ijantimicag.2017.10.004","volume":"51","author":"M Kaushik","year":"2018","unstructured":"Kaushik, M., Kumar, S., Kapoor, R. K., Virdi, J. S. & Gulati, P. Integrons in Enterobacteriaceae: diversity, distribution and epidemiology. Int. J. Antimicrob. Agents 51, 167\u2013176. https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.10.004 (2018).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"80272_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/jpn.12666","volume":"102","author":"THT Tran","year":"2018","unstructured":"Tran, T. H. T., Everaert, N. & Bindelle, J. Review on the effects of potential prebiotics on controlling intestinal enteropathogens Salmonella and Escherichia coli in pig production. J. Anim. Physiol. Anim. Nutr. 102, 17\u201332. https:\/\/doi.org\/10.1111\/jpn.12666 (2018).","journal-title":"J. Anim. Physiol. Anim. Nutr."},{"key":"80272_CR3","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1128\/AAC.47.2.626-635.2003","volume":"47","author":"FS Aliabadi","year":"2003","unstructured":"Aliabadi, F. S., Landoni, M. F. & Lees, P. Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of danofloxacin in sheep biological fluids. Antimicrob. Agents Chemother. 47, 626\u2013635 (2003).","journal-title":"Antimicrob. Agents Chemother."},{"key":"80272_CR4","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/jac\/dki079","volume":"55","author":"JW Mouton","year":"2005","unstructured":"Mouton, J. W., Dudley, M. N., Cars, O., Derendorf, H. & Drusano, G. L. Standardization of pharmacokinetic\/pharmacodynamic (PK\/PD) terminology for anti-infective drugs: an update. J. Antimicrobial Chemother. 55, 601\u2013607. https:\/\/doi.org\/10.1093\/jac\/dki079 (2005).","journal-title":"J. Antimicrobial Chemother."},{"key":"80272_CR5","unstructured":"WHO. Antimicrobial resistance: global report on surveillance. (World Health Organization, London, 2014)."},{"key":"80272_CR6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.tim.2013.12.007","volume":"22","author":"TF Schaberle","year":"2014","unstructured":"Schaberle, T. F. & Hack, I. M. Overcoming the current deadlock in antibiotic research. Trends Microbiol. 22, 165\u2013167. https:\/\/doi.org\/10.1016\/j.tim.2013.12.007 (2014).","journal-title":"Trends Microbiol."},{"key":"80272_CR7","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1001\/jama.2016.11764","volume":"316","author":"HD Marston","year":"2016","unstructured":"Marston, H. D., Dixon, D. M., Knisely, J. M., Palmore, T. N. & Fauci, A. S. Antimicrobial resistance. JAMA 316, 1193\u20131204. https:\/\/doi.org\/10.1001\/jama.2016.11764 (2016).","journal-title":"JAMA"},{"key":"80272_CR8","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.rvsc.2014.10.012","volume":"97","author":"CD Warren","year":"2014","unstructured":"Warren, C. D. et al. Implantation of an ultrafiltration device in the ileum and spiral colon of steers to continuously collect intestinal fluid. Res. Vet. Sci. 97, 611\u2013615 (2014).","journal-title":"Res. Vet. Sci."},{"key":"80272_CR9","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/sj.bjp.0706974","volume":"150","author":"JA Schrickx","year":"2007","unstructured":"Schrickx, J. A. & Fink-Gremmels, J. Danofloxacin-mesylate is a substrate for ATP-dependent efflux transporters. Br. J. Pharmacol. 150, 463\u2013469. https:\/\/doi.org\/10.1038\/sj.bjp.0706974 (2007).","journal-title":"Br. J. Pharmacol."},{"key":"80272_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/(SICI)1099-0801(200004)14:2<89::AID-BMC931>3.0.CO;2-N","volume":"14","author":"MA Garcia","year":"2000","unstructured":"Garcia, M. A., Solans, C., Aramayona, J. J., Rueda, S. & Bregante, M. A. Development of a method for the determination of danofloxacin in plasma by HPLC with fluorescence detection. Biomed. Chromatogr. BMC 14, 89\u201392. https:\/\/doi.org\/10.1002\/(SICI)1099-0801(200004)14:2%3c89::AID-BMC931%3e3.0.CO;2-N (2000).","journal-title":"Biomed. Chromatogr. BMC"},{"key":"80272_CR11","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/BF01062109","volume":"6","author":"K Yamaoka","year":"1978","unstructured":"Yamaoka, K., Nakagawa, T. & Uno, T. Statistical moments in pharmacokinetics. J. Pharmacokinet. Biopharm. 6, 547\u2013558 (1978).","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"80272_CR12","unstructured":"CLSI. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals. 4th ed. CLSI supplement VET08. Wayne, PA: Clinical and Laboratory Standards Institute (2018)."},{"key":"80272_CR13","unstructured":"CLSI. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals. 5th ed. CLSI standard VET01. Wayne, PA: Clinical and Laboratory Standards Institute (2018)."},{"key":"80272_CR14","doi-asserted-by":"publisher","first-page":"S147","DOI":"10.1086\/321841","volume":"33","author":"X Zhao","year":"2001","unstructured":"Zhao, X. & Drlica, K. Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinolone studies. Clin. Infect. Dis. 33, S147\u2013S156 (2001).","journal-title":"Clin. Infect. Dis."},{"key":"80272_CR15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fmicb.2016.00036","volume":"7","author":"J Wang","year":"2016","unstructured":"Wang, J. et al. Pharmacokinetic and pharmacodynamic integration and modeling of enrofloxacin in swine for Escherichia coli. Front. Microbiol. 7, 36. https:\/\/doi.org\/10.3389\/fmicb.2016.00036 (2016).","journal-title":"Front. Microbiol."},{"key":"80272_CR16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0034-5288(02)00039-5","volume":"73","author":"PL Toutain","year":"2002","unstructured":"Toutain, P. L., del Castillo, J. R. & Bousquet-Melou, A. The pharmacokinetic-pharmacodynamic approach to a rational dosage regimen for antibiotics. Res. Vet. Sci. 73, 105\u2013114 (2002).","journal-title":"Res. Vet. Sci."},{"key":"80272_CR17","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1124\/pr.111.005769","volume":"65","author":"EI Nielsen","year":"2013","unstructured":"Nielsen, E. I. & Friberg, L. E. Pharmacokinetic-pharmacodynamic modeling of antibacterial drugs. Pharmacol. Rev. 65, 1053\u20131090. https:\/\/doi.org\/10.1124\/pr.111.005769 (2013).","journal-title":"Pharmacol. Rev."},{"key":"80272_CR18","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.2460\/ajvr.1992.53.06.1022","volume":"53","author":"DD Mann","year":"1992","unstructured":"Mann, D. D. & Frame, G. M. Pharmacokinetic study of danofloxacin in cattle and swine. Am. J. Vet. Res. 53, 1022\u20131026 (1992).","journal-title":"Am. J. Vet. Res."},{"key":"80272_CR19","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s11259-009-9320-6","volume":"33","author":"C Wang","year":"2009","unstructured":"Wang, C. et al. Preparation and evaluation of danofloxacin mesylate microspheres and its pharmacokinetics in pigs. Vet. Res. Commun. 33, 1013\u20131022. https:\/\/doi.org\/10.1007\/s11259-009-9320-6 (2009).","journal-title":"Vet. Res. Commun."},{"key":"80272_CR20","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/bcpt.12147","volume":"114","author":"LA Rottb\u00f8ll","year":"2014","unstructured":"Rottb\u00f8ll, L. A. & Friis, C. Microdialysis as a tool for drug quantification in the bronchioles of anaesthetized pigs. Basic Clin. Pharmacol. Toxicol. 114, 226\u2013232 (2014).","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"80272_CR21","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.ijantimicag.2013.07.008","volume":"42","author":"AA Ferran","year":"2013","unstructured":"Ferran, A. A. et al. Pharmacokinetic\/pharmacodynamic assessment of the effects of parenteral administration of a fluoroquinolone on the intestinal microbiota: comparison of bactericidal activity at the gut versus the systemic level in a pig model. Int. J. Antimicrob. Agents 42, 429\u2013435. https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.07.008 (2013).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"80272_CR22","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.2527\/1997.7582248x","volume":"75","author":"DL Harmon","year":"1997","unstructured":"Harmon, D. L. & Richards, C. J. Considerations for gastrointestinal cannulations in ruminants. J. Anim. Sci. 75, 2248\u20132255 (1997).","journal-title":"J. Anim. Sci."},{"key":"80272_CR23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/j.1365-2885.2005.00664.x","volume":"28","author":"TL Bidgood","year":"2005","unstructured":"Bidgood, T. L. & Papich, M. G. Plasma and interstitial fluid pharmacokinetics of enrofloxacin, its metabolite ciprofloxacin, and marbofloxacin after oral administration and a constant rate intravenous infusion in dogs. J. Vet. Pharmacol. Ther. 28, 329\u2013341. https:\/\/doi.org\/10.1111\/j.1365-2885.2005.00664.x (2005).","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"80272_CR24","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/j.1365-2885.2007.00914.x","volume":"30","author":"JL Davis","year":"2007","unstructured":"Davis, J. L., Foster, D. M. & Papich, M. G. Pharmacokinetics and tissue distribution of enrofloxacin and its active metabolite ciprofloxacin in calves. J. Vet. Pharmacol. Ther. 30, 564\u2013571. https:\/\/doi.org\/10.1111\/j.1365-2885.2007.00914.x (2007).","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"80272_CR25","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1053\/rvsc.1999.0361","volume":"68","author":"RH Lindecrona","year":"2000","unstructured":"Lindecrona, R. H., Friis, C. & Nielsen, J. P. Pharmacokinetics and penetration of danofloxacin into the gastrointestinal tract in healthy and in Salmonella typhimurium infected pigs. Res. Vet. Sci. 68, 211\u2013216. https:\/\/doi.org\/10.1053\/rvsc.1999.0361 (2000).","journal-title":"Res. Vet. Sci."},{"key":"80272_CR26","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1093\/jac\/dkl135","volume":"57","author":"SK Olofsson","year":"2006","unstructured":"Olofsson, S. K., Marcusson, L. L., Komp Lindgren, P., Hughes, D. & Cars, O. Selection of ciprofloxacin resistance in Escherichia coli in an in vitro kinetic model: relation between drug exposure and mutant prevention concentration. J. Antimicrobial Chemother. 57, 1116\u20131121. https:\/\/doi.org\/10.1093\/jac\/dkl135 (2006).","journal-title":"J. Antimicrobial Chemother."},{"key":"80272_CR27","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0034-5288(03)00029-8","volume":"74","author":"B Lauritzen","year":"2003","unstructured":"Lauritzen, B., Lykkesfeldt, J. & Friis, C. Evaluation of a single dose versus a divided dose regimen of danofloxacin in treatment of Actinobacillus pleuropneumoniae infection in pigs. Res. Vet. Sci. 74, 271\u2013277 (2003).","journal-title":"Res. Vet. Sci."},{"issue":"Suppl 1","key":"80272_CR28","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.1086\/518137","volume":"45","author":"GL Drusano","year":"2007","unstructured":"Drusano, G. L. Pharmacokinetics and pharmacodynamics of antimicrobials. Clin. Infect. Dis. 45(Suppl 1), S89-95. https:\/\/doi.org\/10.1086\/518137 (2007).","journal-title":"Clin. Infect. Dis."},{"key":"80272_CR29","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1128\/AAC.46.6.1665-1670.2002","volume":"46","author":"D Andes","year":"2002","unstructured":"Andes, D. & Craig, W. A. Pharmacodynamics of the new fluoroquinolone gatifloxacin in murine thigh and lung infection models. Antimicrob. Agents Chemother. 46, 1665\u20131670 (2002).","journal-title":"Antimicrob. Agents Chemother."},{"key":"80272_CR30","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1128\/AAC.37.5.1073","volume":"37","author":"A Forrest","year":"1993","unstructured":"Forrest, A. et al. Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrob. Agents Chemother. 37, 1073\u20131081 (1993).","journal-title":"Antimicrob. Agents Chemother."},{"key":"80272_CR31","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/jac\/46.5.669","volume":"46","author":"DH Wright","year":"2000","unstructured":"Wright, D. H., Brown, G. H., Peterson, M. L. & Rotschafer, J. C. Application of fluoroquinolone pharmacodynamics. J. Antimicrobial Chemother. 46, 669\u2013683 (2000).","journal-title":"J. Antimicrobial Chemother."},{"key":"80272_CR32","doi-asserted-by":"publisher","first-page":"3659","DOI":"10.1128\/AAC.00670-13","volume":"57","author":"L Zhang","year":"2013","unstructured":"Zhang, L., Huang, Y., Zhou, Y., Buckley, T. & Wang, H. H. Antibiotic administration routes significantly influence the levels of antibiotic resistance in gut microbiota. Antimicrob. Agents Chemother. 57, 3659\u20133666. https:\/\/doi.org\/10.1128\/AAC.00670-13 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"80272_CR33","doi-asserted-by":"publisher","first-page":"4973","DOI":"10.1128\/AAC.06402-11","volume":"56","author":"TT Nguyen","year":"2012","unstructured":"Nguyen, T. T. et al. Correlation between fecal concentrations of ciprofloxacin and fecal counts of resistant Enterobacteriaceae in piglets treated with ciprofloxacin: toward new means to control the spread of resistance?. Antimicrob. Agents Chemother. 56, 4973\u20134975. https:\/\/doi.org\/10.1128\/AAC.06402-11 (2012).","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80272-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80272-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80272-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T06:42:26Z","timestamp":1724308946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80272-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,12]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["80272"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-80272-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,12]]},"assertion":[{"value":"10 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"681"}}